Cargando…
Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641548/ https://www.ncbi.nlm.nih.gov/pubmed/37965187 http://dx.doi.org/10.1016/j.jdcr.2023.09.006 |
| _version_ | 1785146793180266496 |
|---|---|
| author | Robinson, Warner McLellan, Beth N. |
| author_facet | Robinson, Warner McLellan, Beth N. |
| author_sort | Robinson, Warner |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10641548 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106415482023-11-14 Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus Robinson, Warner McLellan, Beth N. JAAD Case Rep Case Report Elsevier 2023-09-26 /pmc/articles/PMC10641548/ /pubmed/37965187 http://dx.doi.org/10.1016/j.jdcr.2023.09.006 Text en © 2023 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Robinson, Warner McLellan, Beth N. Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_full | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_fullStr | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_full_unstemmed | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_short | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_sort | incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641548/ https://www.ncbi.nlm.nih.gov/pubmed/37965187 http://dx.doi.org/10.1016/j.jdcr.2023.09.006 |
| work_keys_str_mv | AT robinsonwarner incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus AT mclellanbethn incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus |